These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Beta adrenergic drugs in arterial hypertension]. Gysling E Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882 [No Abstract] [Full Text] [Related]
27. [Effect of beta blockade on the erythrocyte transport of Na+: evaluation during stimulation by cold pressure test in patients with essential hypertension]. Saitta A; Saitta MN; Bonaiuto M; Castaldo M; Sardo A; Messina A; Cinquegrani M; Squadrito G; Campo GM; Squadrito F Clin Ter; 1997; 148(5-6):237-47. PubMed ID: 9377859 [TBL] [Abstract][Full Text] [Related]
28. [Clinical application of beta-blockaders]. Offerhaus L Ned Tijdschr Geneeskd; 1973 May; 117(21):814-21. PubMed ID: 4150242 [No Abstract] [Full Text] [Related]
29. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. Hansson L Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751 [No Abstract] [Full Text] [Related]
30. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Man in't Veld AJ; Schalekamp MA Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800 [TBL] [Abstract][Full Text] [Related]
31. Prorenin and beta-blockade in hypertension. McKenna F; Davison AM Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678 [TBL] [Abstract][Full Text] [Related]
32. [Central effects of beta adrenergic receptor blockaders, obsidan and trasicor, in arterial hypertension]. Kukes VG; Kazarian AB; Sozinov VN; Paramonov LV; Kniazev RP Sov Med; 1989; (8):61-3. PubMed ID: 2814668 [No Abstract] [Full Text] [Related]
34. [Treatment of disorders of cardiac rhythm with beta-adrenoblockaders]. Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL Klin Med (Mosk); 1985 Aug; 63(8):41-8. PubMed ID: 2867248 [No Abstract] [Full Text] [Related]
35. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension]. Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850 [TBL] [Abstract][Full Text] [Related]
36. [Improved prognosis using beta blockers after myocardial infarct?]. Weisswange A Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479 [No Abstract] [Full Text] [Related]
37. Ten years experience with the use of B-adrenergic blockers in the pre-operative preparation of thyrotoxic patients. Bashir AY; Nasef A; Ibrahim AH; Kenawi MM; El-Malek WA; Ageeb M J Egypt Med Assoc; 1978; 61(1-2):1-9. PubMed ID: 41011 [No Abstract] [Full Text] [Related]
38. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH). Békés M; Matos L; Rausch J; Török E Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774 [No Abstract] [Full Text] [Related]
39. On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol. Bravo EL; Tarazi RC; Dustan HP J Lab Clin Med; 1974 Jan; 83(1):119-28. PubMed ID: 4808650 [No Abstract] [Full Text] [Related]
40. Combined treatment of hypertension with vasodilatation and beta-adrenergic blockade. Hansson L; Zweifler AJ Mich Med; 1973 Oct; 72(30):695-8. PubMed ID: 4147721 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]